Endomyocardial biopsy and selective coronary angiography are low-risk procedures in pediatric heart transplant recipients: results of a multicenter experience.
Endomyocardial biopsy and selective coronary angiography are low-risk procedures in pediatric heart transplant recipients: results of a multicenter experience.
复制标题
DOI:
10.1016/j.healun.2011.11.019
复制
发表时间:
2012-04
期刊:
影响因子:
--
通讯作者:
Bergersen L
中科院分区:
文献类型:
--
作者:
Daly KP;Marshall AC;Vincent JA;Zuckerman WA;Hoffman TM;Canter CE;Blume ED;Bergersen L
No prior reports documenting the safety and diagnostic yield of cardiac catheterization and endomyocardial biopsy (EMB) in heart transplant recipients include multicenter data. Data on the safety and diagnostic yield of EMB procedures performed in heart transplant recipients were recorded in the Congenital Cardiac Catheterization Outcomes Project database at 8 pediatric centers over a 3 year period. Adverse events (AE) were classified according to a 5 level severity scale. Generalized estimating equation models identified risk factors for high severity adverse events (HSAE) (Levels 3-5) and non-diagnostic biopsy samples. A total of 2665 EMB cases were performed in 744 pediatric heart transplant recipients (median age 12 years [IQR: 4.8,16.7] and 54% male). AE occurred in 88 cases (3.3%), of which 28 (1.1%) were HSAE. AE attributable to EMB included tricuspid valve injury, transient complete heart block, and RBBB. Amongst 822 cases involving coronary angiography, 10 (1.2%) resulted in a coronary related AE. There were no myocardial perforations or deaths. Multivariable risk factors for HSAE included fewer prior catheterizations (p=0.006) and longer case length (p=<0.001). EMB yielded sufficient tissue for diagnosis in 99% of cases. Longer time since heart transplant was the most significant predictor of a non-diagnostic biopsy sample (p<0.001). In the current era, cardiac catheterizations involving EMB can be performed in pediatric heart transplant recipients with a low AE rate and high diagnostic yield. Risk of HSAE is increased in early post-transplant biopsies and with longer case length. Longer time since heart transplant is associated with non-diagnostic EMB sample.
登录
查看更多内容
影响因子:
0.3
作者:
Bergersen, Lisa;Gauvreau, Kimberlee;Lock, James E
通讯作者:
Lock, James E
影响因子:
8.9
作者:
Baris, Nezihi;Sipahi, Ilke;Tuzcu, E. Murat
通讯作者:
Tuzcu, E. Murat
影响因子:
5.1
作者:
Chin, C;Akhtar, MJ;Bernstein, D
通讯作者:
Bernstein, D
影响因子:
1.3
作者:
Levi, DS;DeConde, AS;Wetzel, GT
通讯作者:
Wetzel, GT
影响因子:
8.9
作者:
Kfoury, Abdallah G.;Hammond, M. Elizabeth H.
通讯作者:
Hammond, M. Elizabeth H.